Pei-jian Peng

发表

Phase II clinical study of gemcitabine in the treatment of patients with advanced nasopharyngeal carcinoma after the failure of platinum-based chemotherapy

Yang Zhang, Z. Guan, Pei-yu Huang, 2007, Cancer Chemotherapy and Pharmacology.

Development and External Validation of Nomograms for Predicting Survival in Nasopharyngeal Carcinoma Patients after Definitive Radiotherapy

S. Liang, Yan Wang, Yong Chen, 2015, Scientific Reports.

Development and external validation of nomograms to predict the risk of skeletal metastasis at the time of diagnosis and skeletal metastasis-free survival in nasopharyngeal carcinoma

S. Liang, Yan Wang, Yong Chen, 2017, BMC Cancer.

Dose escalation and expansion (phase Ia/Ib) study of GLS-010, a recombinant fully human antiprogrammed death-1 monoclonal antibody for advanced solid tumors or lymphoma.

P. Lu, Jianji Pan, Y. Ba, 2021, European journal of cancer.

KRAS mutation-induced upregulation of PD-L1 mediates immune escape in human lung adenocarcinoma

N. Chen, Li Zhang, W. Fang, 2017, Cancer Immunology, Immunotherapy.

miR-429 suppresses cell proliferation, migration and invasion in nasopharyngeal carcinoma by downregulation of TLN1

Zibin Liang, Zhong Lin, Jianxun Chen, 2019, Cancer Cell International.

Efficacy and safety of pemetrexed and nedaplatin followed by pemetrexed maintenance therapy in advanced lung adenocarcinoma

Si-yang Wang, Zhong Lin, Weize Lv, 2017, Cancer management and research.

Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial

Jianji Pan, Xiaozhong Chen, Rensheng Wang, 2016, The Lancet.

Association between PD-L1 Expression on Tumour-Infiltrating Lymphocytes and Overall Survival in Patients with Gastric Cancer

Li Zhang, W. Fang, T. Zhou, 2017, Journal of Cancer.

Histologic lung cancer subtype differentiates synchronous multiple primary lung adenocarcinomas from intrapulmonary metastases.

B. Lei, P. Peng, Xiaojin Wang, 2017, The Journal of surgical research.

Phase II trial of docetaxel combined with nedaplatin for patients with recurrent and metastatic nasopharyngeal carcinoma

Si-yang Wang, H. Liao, Zhong Lin, 2015, Drug design, development and therapy.

Low Prognostic Nutritional Index (PNI) Predicts Unfavorable Distant Metastasis-Free Survival in Nasopharyngeal Carcinoma: A Propensity Score-Matched Analysis

S. Liang, Yan Wang, Yong Chen, 2016, PloS one.

Phase III study comparing standard radiotherapy with or without weekly oxaliplatin in treatment of locoregionally advanced nasopharyngeal carcinoma: preliminary results.

Chong Zhao, Pei-yu Huang, F. Han, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Gemcitabine Plus Cisplatin Versus Fluorouracil Plus Cisplatin as First-Line Therapy for Recurrent or Metastatic Nasopharyngeal Carcinoma: Final Overall Survival Analysis of GEM20110714 Phase III Study

Jianji Pan, Xiaozhong Chen, Rensheng Wang, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The association between PD-L1 and EGFR status and the prognostic value of PD-L1 in advanced non-small cell lung cancer patients treated with EGFR-TKIs

Ge Li, N. Chen, Li Zhang, 2015, Oncotarget.

Phase II Study of a Bi-Weekly Chemotherapy Regimen of Combined Liposomal Paclitaxel and Nedaplatin for the Treatment of Advanced Squamous Cell Lung Cancer

Si-yang Wang, Zhong Lin, Weize Lv, 2019, Translational oncology.

Cholesterol synthesis disruption combined with a molecule-targeted drug is a promising metabolic therapy for EGFR mutant non-small cell lung cancer

Li Zhang, W. Fang, Yun-peng Yang, 2021, Translational lung cancer research.

Everolimus enhances cellular cytotoxicity of lapatinib via the eukaryotic elongation factor-2 kinase pathway in nasopharyngeal carcinoma cells

N. Chen, P. Peng, Zhong Lin, 2016, OncoTargets and therapy.

miR-429 suppresses cell proliferation, migration and invasion in nasopharyngeal carcinoma by downregulation of TLN1

Zibin Liang, Zhong Lin, Jianxun Chen, 2019, Cancer cell international.

Multicenter phase II study of capecitabine combined with nedaplatin for recurrent and metastatic nasopharyngeal carcinoma patients after failure of cisplatin-based chemotherapy

Hong-Yu Zhang, Si-yang Wang, H. Liao, 2013, Cancer Chemotherapy and Pharmacology.

Phase II study of gemcitabine plus S-1 chemotherapy in recurrent and metastatic nasopharyngeal carcinoma patients after failure of platinum-based chemotherapy

Si-yang Wang, H. Liao, Zhong Lin, 2016, Therapeutic advances in medical oncology.

Safety and efficacy of S-1 chemotherapy in recurrent and metastatic nasopharyngeal carcinoma patients after failure of platinum-based chemotherapy: multi-institutional retrospective analysis

Si-yang Wang, Yan Tang, Zhong Lin, 2014, Drug design, development and therapy.

Perineural Invasion and TAMs in Pancreatic Ductal Adenocarcinomas: Review of the Original Pathology Reports Using Immunohistochemical Enhancement and Relationships with Clinicopathological Features

H. Su, Jian-zhong Liang, Yubo Guo, 2014, Journal of Cancer.

Development and external validation of nomograms to predict the risk of skeletal metastasis at the time of diagnosis and skeletal metastasis-free survival in nasopharyngeal carcinoma

S. Liang, Yan Wang, Yong Chen, 2017, BMC Cancer.

Inhibition of eEF-2 kinase sensitizes human nasopharyngeal carcinoma cells to lapatinib-induced apoptosis through the Src and Erk pathways

N. Chen, Pei-yu Huang, Zhong Lin, 2016, BMC Cancer.

CD47 Overexpression Is Associated with Epstein–Barr Virus Infection and Poor Prognosis in Patients with Nasopharyngeal Carcinoma

Li Zhang, Xiaofeng Pei, Zhong Lin, 2020, OncoTargets and therapy.

Dose Escalation of Lobaplatin Concurrent with IMRT for the Treatment of Stage III-IVb NPC: A Phase I Clinical Trial23

Bin Zhou, Ji-Jin Yao, Si-yang Wang, 2018, Translational oncology.

Multi-institutional prospective study of nedaplatin plus S-1 chemotherapy in recurrent and metastatic nasopharyngeal carcinoma patients after failure of platinum-containing regimens

Pei-yu Huang, H. Liao, Zhong Lin, 2017, Therapeutic advances in medical oncology.

Inhibition of eEF-2 kinase sensitizes human nasopharyngeal carcinoma cells to lapatinib-induced apoptosis through the Src and Erk pathways

N. Chen, Pei-yu Huang, P. Peng, 2016, BMC Cancer.

Dose Escalation of Lobaplatin Concurrent with IMRT for the Treatment of Stage III-IVb NPC : A Phase I Clinical Trial 2 , 3

Bin Zhou, Ji-Jin Yao, Si-yang Wang, 2018 .